Zhan‐Miao Yi

Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study

E. Clay, Junwen Zhou, Zhan‐Miao Yi et al. · Journal of Market Access & Health Policy · 2019 · 32 citations · Full text

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

Zhan‐Miao Yi, Cheng Wen, Ting Cai et al. · Neuropsychiatric Disease and Treatment · 2018 · 29 citations · Full text

An evaluation of clinical pharmacist service on a neurology care unit

Zhan‐Miao Yi, Shusen Sun, Xiaoxiao Li et al. · International Journal of Clinical Pharmacy · 2015 · 17 citations

Neurology Care Unit, Patient Safety, Pharmaceutical Care +7

Evaluating the direct medical cost, drug utilization and expenditure for managing Parkinson’s disease: a costing study at a medical center in China

Zhan‐Miao Yi, Xinya Li, Yubo Wang et al. · Annals of Translational Medicine · 2022 · 16 citations · Full text

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation

Zhan‐Miao Yi, Tingting Qiu, Yuan Zhang et al. · Therapeutics and Clinical Risk Management · 2018 · 12 citations · Full text